• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结构和生化洞察 EIAV gp45 疫苗株中发现的 V/I505T 突变。

Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain.

机构信息

State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin 300071, China.

出版信息

Retrovirology. 2014 Mar 21;11:26. doi: 10.1186/1742-4690-11-26.

DOI:10.1186/1742-4690-11-26
PMID:24656154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3997929/
Abstract

BACKGROUND

The equine infectious anemia virus (EIAV) is a lentivirus of the Retrovirus family, which causes persistent infection in horses often characterized by recurrent episodes of high fever. It has a similar morphology and life cycle to the human immunodeficiency virus (HIV). Its transmembrane glycoprotein, gp45 (analogous to gp41 in HIV), mediates membrane fusion during the infection. However, the post-fusion conformation of EIAV gp45 has not yet been determined. EIAV is the first member of the lentiviruses for which an effective vaccine has been successfully developed. The attenuated vaccine strain, FDDV, has been produced from a pathogenic strain by a series of passages in donkey dermal cells. We have previously reported that a V/I505T mutation in gp45, in combination with other mutations in gp90, may potentially contribute to the success of the vaccine strain. To this end, we now report on our structural and biochemical studies of the gp45 protein from both wide type and vaccine strain, providing a valuable structural model for the advancement of the EIAV vaccine.

RESULTS

We resolved crystal structures of the ecto-domain of gp45 from both the wild-type EIAV and the vaccine strain FDDV. We found that the V/I505T mutation in gp45 was located in a highly conserved d position within the heptad repeat, which protruded into a 3-fold symmetry axis within the six-helix bundle. Our crystal structure analyses revealed a shift of a hydrophobic to hydrophilic interaction due to this specific mutation, and further biochemical and virological studies confirmed that the mutation reduced the overall stability of the six-helix bundle in post-fusion conformation. Moreover, we found that altering the temperatures drastically affected the viral infectivity.

CONCLUSIONS

Our high-resolution crystal structures of gp45 exhibited high conservation between the gp45/gp41 structures of lentiviruses. In addition, a hydrophobic to hydrophilic interaction change in the EIAV vaccine strain was found to modulate the stability and thermal-sensitivity of the overall gp45 structure. Our observations suggest that lowering the stability of the six-helix bundle (post-fusion), which may stabilizes the pre-fusion conformation, might be one of the reasons of acquired dominance for FDDV in viral attenuation.

摘要

背景

马传染性贫血病毒(EIAV)是逆转录病毒科的慢病毒,可导致马的持续性感染,通常表现为反复发作的高热。它的形态和生命周期与人类免疫缺陷病毒(HIV)相似。其跨膜糖蛋白 gp45(与 HIV 中的 gp41 类似)在感染过程中介导膜融合。然而,EIAV gp45 的融合后构象尚未确定。EIAV 是第一种成功开发出有效疫苗的慢病毒。减毒疫苗株 FDDV 是通过在驴皮肤细胞中进行一系列传代从致病性毒株中产生的。我们之前报道过,gp45 中的 V/I505T 突变与 gp90 中的其他突变相结合,可能有助于疫苗株的成功。为此,我们现在报告了对来自野生型和疫苗株的 gp45 蛋白的结构和生化研究,为 EIAV 疫苗的发展提供了有价值的结构模型。

结果

我们解析了来自野生型 EIAV 和疫苗株 FDDV 的 gp45 外显子结构的晶体结构。我们发现,gp45 中的 V/I505T 突变位于七肽重复中的高度保守的 d 位,该突变突出到六螺旋束的 3 倍对称轴内。我们的晶体结构分析显示,由于这种特定突变,疏水相互作用转变为亲水相互作用,进一步的生化和病毒学研究证实,该突变降低了融合后构象中六螺旋束的整体稳定性。此外,我们发现改变温度会极大地影响病毒的感染力。

结论

我们的 gp45 高分辨率晶体结构显示了慢病毒的 gp45/gp41 结构之间的高度保守性。此外,在 EIAV 疫苗株中发现的疏水到亲水相互作用的变化调节了整个 gp45 结构的稳定性和热敏感性。我们的观察结果表明,降低六螺旋束(融合后)的稳定性,可能稳定融合前构象,这可能是 FDDV 在病毒减毒中获得优势的原因之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52dd/3997929/cae0ae5f87d3/1742-4690-11-26-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52dd/3997929/d09b1ad512ed/1742-4690-11-26-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52dd/3997929/d1a34fa3931e/1742-4690-11-26-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52dd/3997929/23811f199c86/1742-4690-11-26-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52dd/3997929/cae0ae5f87d3/1742-4690-11-26-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52dd/3997929/d09b1ad512ed/1742-4690-11-26-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52dd/3997929/d1a34fa3931e/1742-4690-11-26-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52dd/3997929/23811f199c86/1742-4690-11-26-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52dd/3997929/cae0ae5f87d3/1742-4690-11-26-4.jpg

相似文献

1
Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain.结构和生化洞察 EIAV gp45 疫苗株中发现的 V/I505T 突变。
Retrovirology. 2014 Mar 21;11:26. doi: 10.1186/1742-4690-11-26.
2
Structural and functional characterization of EIAV gp45 fusion peptide proximal region and asparagine-rich layer.马传染性贫血病毒gp45融合肽近端区域和富含天冬酰胺层的结构与功能特征
Virology. 2016 Apr;491:64-72. doi: 10.1016/j.virol.2016.01.010. Epub 2016 Feb 11.
3
C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity.末端截断的衰减型慢病毒疫苗跨膜蛋白改变其体外但不改变其体内复制能力,从而减弱其潜在的致病性。
Virus Res. 2011 Jun;158(1-2):235-45. doi: 10.1016/j.virusres.2011.04.007. Epub 2011 Apr 22.
4
Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus-1 gp41 and equine infectious anemia virus gp45.从人类免疫缺陷病毒1型gp41和马传染性贫血病毒gp45的晶体结构洞察获得性免疫缺陷综合征疫苗的开发
Protein Sci. 2015 Oct;24(10):1549-59. doi: 10.1002/pro.2750. Epub 2015 Sep 21.
5
Cloning, expression and preliminary crystallographic analysis of the equine infectious anaemia virus (EIAV) gp45 ectodomain.马传染性贫血病毒(EIAV)gp45胞外结构域的克隆、表达及初步晶体学分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Apr 1;67(Pt 4):482-5. doi: 10.1107/S174430911100460X. Epub 2011 Mar 25.
6
[Construction and in vitro evaluation of an infectious clone of the equine infectious anemia virus vaccine strain EIAV(FDDV) with four reverse-mutated vaccine-specific sites in the S2 gene].[具有S2基因四个反向突变疫苗特异性位点的马传染性贫血病毒疫苗株EIAV(FDDV)感染性克隆的构建及体外评价]
Bing Du Xue Bao. 2009 Jul;25(4):309-15.
7
Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.包膜糖蛋白 gp90 蛋白中的氨基酸突变修饰了中国 EIAV 疫苗株的 N 连接糖基化,增强了对中和抗体的抵抗力。
Viral Immunol. 2010 Oct;23(5):531-9. doi: 10.1089/vim.2009.0006.
8
Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides.来自感染马传染性贫血病毒(EIAV)的带毒马的抗体和外周血单核细胞(PBMC)可识别gp45和p26合成肽。
Vet Immunol Immunopathol. 2005 Dec 15;108(3-4):335-43. doi: 10.1016/j.vetimm.2005.06.007. Epub 2005 Aug 18.
9
Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.与马传染性贫血病毒保护性免疫相关的包膜特异性辅助性T细胞和细胞毒性T淋巴细胞反应。
J Gen Virol. 2007 Apr;88(Pt 4):1324-1336. doi: 10.1099/vir.0.82391-0.
10
Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.在马传染性贫血病毒减毒与疫苗效力之间找到有效的平衡。
J Virol. 2005 Mar;79(5):2666-77. doi: 10.1128/JVI.79.5.2666-2677.2005.

引用本文的文献

1
On the irrationality of rational design of an HIV vaccine in light of protein intrinsic disorder.鉴于蛋白质固有无序性,HIV 疫苗理性设计的不合理性。
Arch Virol. 2021 May;166(5):1283-1296. doi: 10.1007/s00705-021-04984-5. Epub 2021 Feb 19.
2
HIV Vaccine Mystery and Viral Shell Disorder.HIV 疫苗之谜与病毒外壳紊乱。
Biomolecules. 2019 May 8;9(5):178. doi: 10.3390/biom9050178.
3
Characterization of EIAV Quasispecies during Long-Term Passage In Vitro: Gradual Loss of Pathogenicity.EIAV 准种在体外长期传代过程中的特征:致病性逐渐丧失。

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.从马传染性贫血病毒感染与免疫研究中得到的艾滋病疫苗开发经验教训。
Viruses. 2013 Dec 2;5(12):2963-76. doi: 10.3390/v5122963.
3
Equine infectious anemia and equine infectious anemia virus in 2013: a review.马传染性贫血与马传染性贫血病毒 2013 年研究进展:综述
Viruses. 2019 Apr 24;11(4):380. doi: 10.3390/v11040380.
4
Genetic Evolution during the development of an attenuated EIAV vaccine.减毒马传染性贫血病毒疫苗研发过程中的基因进化
Retrovirology. 2016 Feb 3;13:9. doi: 10.1186/s12977-016-0240-6.
5
The heptad repeat region is a major selection target in MERS-CoV and related coronaviruses.七肽重复区域是中东呼吸综合征冠状病毒及相关冠状病毒的主要选择靶点。
Sci Rep. 2015 Sep 25;5:14480. doi: 10.1038/srep14480.
6
Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus-1 gp41 and equine infectious anemia virus gp45.从人类免疫缺陷病毒1型gp41和马传染性贫血病毒gp45的晶体结构洞察获得性免疫缺陷综合征疫苗的开发
Protein Sci. 2015 Oct;24(10):1549-59. doi: 10.1002/pro.2750. Epub 2015 Sep 21.
Vet Microbiol. 2013 Nov 29;167(1-2):181-204. doi: 10.1016/j.vetmic.2013.09.031. Epub 2013 Oct 12.
4
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer.Cryo-EM 结构的完全糖基化可溶性裂解 HIV-1 包膜三聚体。
Science. 2013 Dec 20;342(6165):1484-90. doi: 10.1126/science.1245627. Epub 2013 Oct 31.
5
Crystal structure of a soluble cleaved HIV-1 envelope trimer.可溶性 HIV-1 包膜三聚体的晶体结构
Science. 2013 Dec 20;342(6165):1477-83. doi: 10.1126/science.1245625. Epub 2013 Oct 31.
6
The crystal structure of HIV CRF07 B'/C gp41 reveals a hyper-mutant site in the middle of HR2 heptad repeat.HIV CRF07 B'/C gp41 的晶体结构揭示了 HR2 七肽重复区中部的一个超突变位点。
Virology. 2013 Nov;446(1-2):86-94. doi: 10.1016/j.virol.2013.07.024. Epub 2013 Aug 25.
7
A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles.一种基于与细菌样颗粒结合的重组融合前形式 F 蛋白的保护性和安全的鼻内 RSV 疫苗。
PLoS One. 2013 Aug 12;8(8):e71072. doi: 10.1371/journal.pone.0071072. eCollection 2013.
8
Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10.常见的耐受机制,但与 gp41 和脂质相关的独特交叉反应性,限制了 HIV-1 广谱中和抗体 2F5 和 4E10 的产生。
J Immunol. 2013 Aug 1;191(3):1260-75. doi: 10.4049/jimmunol.1300770. Epub 2013 Jul 3.
9
Respiratory syncytial virus vaccine development.呼吸道合胞病毒疫苗的研发。
Semin Immunol. 2013 Apr;25(2):160-71. doi: 10.1016/j.smim.2013.04.011. Epub 2013 Jun 15.
10
A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domains.双价重组蛋白通过靶向 CD4 D1D2 结构域诱导的 gp41 预发夹融合中间态来使 HIV-1 失活。
Retrovirology. 2012 Dec 7;9:104. doi: 10.1186/1742-4690-9-104.